Statin therapy for healthy men identified as “increased risk.”
In this featured debate in JAMA, we reviewed the extensive data from randomized clinical trials and observational studies supporting the selective use of lipid lowering therapy in a middle-aged man with hyperlipidemia.
- Journal: Journal of the American Medical Association
- Year: 2012
- Topic: Cholesterol / Lipids / Statins, Cardiovascular Risk Assessment
- Read more articles by: Roger S. Blumenthal, MD, Michael Blaha, MD, MPH, Khurram Nasir, MD, MPH
